Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCPI
Endocrinologist
MRCP (UK), F.C.P.S (Medicine), F.C.P.S (Endocrine)
Endocrinologist
MRCP (UK), F.C.P.S (Medicine), F.C.P.S (Endocrine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Cardiologist
M.B.B.S., F.C.P.S (Medicine), F.C.P.S (Cardiology)
Internal Medicine Specialist
MBBS, MRCP (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology), SCE Endocrinology and Diabetes
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology), SCE Endocrinology and Diabetes
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures